These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 32396700

  • 1. Integrating oral PrEP delivery among African women in a large HIV endpoint-driven clinical trial.
    Beesham I, Welch JD, Heffron R, Pleaner M, Kidoguchi L, Palanee-Phillips T, Ahmed K, Baron D, Bukusi EA, Louw C, Mastro TD, Smit J, Batting JR, Malahleha M, Bailey VC, Beksinska M, Donnell D, Baeten JM, ECHO Trial Consortium.
    J Int AIDS Soc; 2020 May; 23(5):e25491. PubMed ID: 32396700
    [Abstract] [Full Text] [Related]

  • 2. Incorporating oral PrEP into standard prevention services for South African women: a nested interrupted time-series study.
    Donnell D, Beesham I, Welch JD, Heffron R, Pleaner M, Kidoguchi L, Palanee-Phillips T, Ahmed K, Baron D, Bukusi EA, Louw C, Mastro TD, Smit J, Batting JR, Malahleha M, Bailey VC, Beksinska M, Rees H, Baeten JM, ECHO Trial Consortium.
    Lancet HIV; 2021 Aug; 8(8):e495-e501. PubMed ID: 34126052
    [Abstract] [Full Text] [Related]

  • 3. Exploring the Use of Oral Pre-exposure Prophylaxis (PrEP) Among Women from Durban, South Africa as Part of the HIV Prevention Package in a Clinical Trial.
    Beesham I, Heffron R, Evans S, Baeten JM, Smit J, Beksinska M, Mansoor LE.
    AIDS Behav; 2021 Apr; 25(4):1112-1119. PubMed ID: 33106996
    [Abstract] [Full Text] [Related]

  • 4. Integrating preexposure prophylaxis delivery in routine family planning clinics: A feasibility programmatic evaluation in Kenya.
    Mugwanya KK, Pintye J, Kinuthia J, Abuna F, Lagat H, Begnel ER, Dettinger JC, John-Stewart G, Baeten JM, PrEP Implementation for Young Women and Adolescents (PrIYA) Program.
    PLoS Med; 2019 Sep; 16(9):e1002885. PubMed ID: 31479452
    [Abstract] [Full Text] [Related]

  • 5. Brief Report: Quantifiable Plasma Tenofovir Among South African Women Using Daily Oral Pre-exposure Prophylaxis During the ECHO Trial.
    Beesham I, Mansoor LE, Joseph Davey DL, Palanee-Phillips T, Smit J, Ahmed K, Selepe P, Louw C, Singata-Madliki M, Kotze P, Heffron R, Parikh UM, Wiesner L, Rees H, Baeten JM, Beksinska M.
    J Acquir Immune Defic Syndr; 2022 Sep 01; 91(1):26-30. PubMed ID: 35972853
    [Abstract] [Full Text] [Related]

  • 6. Daily Oral Pre-exposure Prophylaxis (PrEP) Continuation Among Women from Durban, South Africa, Who Initiated PrEP as Standard of Care for HIV Prevention in a Clinical Trial.
    Beesham I, Joseph Davey DL, Beksinska M, Bosman S, Smit J, Mansoor LE.
    AIDS Behav; 2022 Aug 01; 26(8):2623-2631. PubMed ID: 35122575
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Enhancing HIV pre-exposure prophylaxis outcomes among Kenyan adolescent girls and young women with a novel pharmacy-based PrEP delivery platform: protocol for a cluster-randomized controlled trial.
    Lagat HK, Pintye J, Harrington E, Houck S, Kwena Z, Lenn M, Mogaka F, Momanyi V, Mugambi M, Nyerere B, Odoyo J, Omollo V, Ortblad KF, Rota G, Sharma M, Bukusi EA.
    Trials; 2024 Jun 19; 25(1):394. PubMed ID: 38890744
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. PrEP use and HIV seroconversion rates in adolescent girls and young women from Kenya and South Africa: the POWER demonstration project.
    Celum CL, Bukusi EA, Bekker LG, Delany-Moretlwe S, Kidoguchi L, Omollo V, Rousseau E, Travill D, Morton JF, Mogaka F, O'Malley G, Barnabee G, van der Straten A, Donnell D, Parikh UM, Kudrick L, Anderson PL, Haberer JE, Wu L, Heffron R, Johnson R, Morrison S, Baeten JM, POWER Study Team.
    J Int AIDS Soc; 2022 Jul 19; 25(7):e25962. PubMed ID: 35822945
    [Abstract] [Full Text] [Related]

  • 13. Preferences for Long-Acting PrEP Products Among Women and Girls: A Quantitative Survey and Discrete Choice Experiment in Eswatini, Kenya, and South Africa.
    Little KM, Hanif H, Anderson SM, Clark MR, Gustafson K, Doncel GF.
    AIDS Behav; 2024 Mar 19; 28(3):936-950. PubMed ID: 37971614
    [Abstract] [Full Text] [Related]

  • 14. Integrated provision of topical pre-exposure prophylaxis in routine family planning services in South Africa: a non-inferiority randomized controlled trial.
    Mansoor LE, Yende-Zuma N, Baxter C, Mngadi KT, Dawood H, Gengiah TN, Samsunder N, Schwartz JL, Doncel GF, Abdool Karim Q.
    J Int AIDS Soc; 2019 Sep 19; 22(9):e25381. PubMed ID: 31507088
    [Abstract] [Full Text] [Related]

  • 15. My Way: development and preliminary evaluation of a novel delivery system for PrEP and other sexual health needs of young women in Western Kenya.
    Haberer JE, Oware K, Juma L, Nyerere B, Momanyi V, Odoyo J, Garrison L, Bhagat J, Musinguzi N, Baeten JM, Siegler A, Bukusi EA.
    J Int AIDS Soc; 2024 Feb 19; 27(2):e26217. PubMed ID: 38379132
    [Abstract] [Full Text] [Related]

  • 16. Key stakeholders' perspectives on providing oral pre-exposure prophylaxis as HIV-prevention standard of care in clinical trials in South Africa.
    Beesham I, Milford C, Joseph Davey DL, Smit J, Mansoor LE, Beksinska M.
    Afr J AIDS Res; 2023 Apr 19; 22(1):18-26. PubMed ID: 36951406
    [Abstract] [Full Text] [Related]

  • 17. Alignment of adherence and risk for HIV acquisition in a demonstration project of pre-exposure prophylaxis among HIV serodiscordant couples in Kenya and Uganda: a prospective analysis of prevention-effective adherence.
    Haberer JE, Kidoguchi L, Heffron R, Mugo N, Bukusi E, Katabira E, Asiimwe S, Thomas KK, Celum C, Baeten JM.
    J Int AIDS Soc; 2017 Jul 25; 20(1):21842. PubMed ID: 28741331
    [Abstract] [Full Text] [Related]

  • 18. The Community PrEP Study: a randomized control trial leveraging community-based platforms to improve access and adherence to pre-exposure prophylaxis to prevent HIV among adolescent girls and young women in South Africa-study protocol.
    Medina-Marino A, Bezuidenhout D, Hosek S, Barnabas RV, Atujuna M, Bezuidenhout C, Ngwepe P, Peters RPH, Little F, Celum CL, Daniels J, Bekker LG.
    Trials; 2021 Jul 26; 22(1):489. PubMed ID: 34311754
    [Abstract] [Full Text] [Related]

  • 19. HIV-1 self-testing to improve the efficiency of pre-exposure prophylaxis delivery: a randomized trial in Kenya.
    Ortblad KF, Kearney JE, Mugwanya K, Irungu EM, Haberer JE, Barnabas RV, Donnell D, Mugo NR, Baeten JM, Ngure K.
    Trials; 2019 Jul 04; 20(1):396. PubMed ID: 31272495
    [Abstract] [Full Text] [Related]

  • 20. Implementation strategies for integrating pre-exposure prophylaxis for HIV prevention and family planning services for adolescent girls and young women in Kenya: a qualitative study.
    Roche SD, Barnabee G, Omollo V, Mogaka F, Odoyo J, Bukusi EA, Morton JF, Johnson R, Celum C, Baeten JM, O'Malley G.
    BMC Health Serv Res; 2022 Mar 30; 22(1):422. PubMed ID: 35354456
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.